nodes	percent_of_prediction	percent_of_DWPC	metapath
Gamma Hydroxybutyric Acid—Hangover—Thalidomide—leprosy	0.0347	0.0394	CcSEcCtD
Gamma Hydroxybutyric Acid—Enuresis—Thalidomide—leprosy	0.0286	0.0325	CcSEcCtD
Gamma Hydroxybutyric Acid—Suicide attempt—Dapsone—leprosy	0.0282	0.032	CcSEcCtD
Gamma Hydroxybutyric Acid—Albuminuria—Dapsone—leprosy	0.0214	0.0243	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC52A2—skin of body—leprosy	0.0186	0.156	CbGeAlD
Gamma Hydroxybutyric Acid—Neck stiffness—Thalidomide—leprosy	0.0172	0.0195	CcSEcCtD
Gamma Hydroxybutyric Acid—Nuchal rigidity—Thalidomide—leprosy	0.0158	0.0179	CcSEcCtD
Gamma Hydroxybutyric Acid—Suicide attempt—Thalidomide—leprosy	0.0144	0.0164	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC52A2—tendon—leprosy	0.0142	0.119	CbGeAlD
Gamma Hydroxybutyric Acid—Enlargement abdomen—Thalidomide—leprosy	0.0136	0.0154	CcSEcCtD
Gamma Hydroxybutyric Acid—Myasthenia—Thalidomide—leprosy	0.013	0.0148	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—eye—leprosy	0.0128	0.107	CbGeAlD
Gamma Hydroxybutyric Acid—Neuralgia—Thalidomide—leprosy	0.0118	0.0134	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC52A2—testis—leprosy	0.0117	0.0986	CbGeAlD
Gamma Hydroxybutyric Acid—Metrorrhagia—Thalidomide—leprosy	0.0115	0.013	CcSEcCtD
Gamma Hydroxybutyric Acid—Psychotic disorder—Dapsone—leprosy	0.0113	0.0129	CcSEcCtD
Gamma Hydroxybutyric Acid—Albuminuria—Thalidomide—leprosy	0.011	0.0124	CcSEcCtD
Gamma Hydroxybutyric Acid—Stupor—Thalidomide—leprosy	0.011	0.0124	CcSEcCtD
Gamma Hydroxybutyric Acid—Amblyopia—Thalidomide—leprosy	0.0106	0.012	CcSEcCtD
Gamma Hydroxybutyric Acid—Nasopharyngitis—Dapsone—leprosy	0.0104	0.0118	CcSEcCtD
Gamma Hydroxybutyric Acid—Muscular weakness—Dapsone—leprosy	0.0102	0.0116	CcSEcCtD
Gamma Hydroxybutyric Acid—Influenza—Dapsone—leprosy	0.01	0.0114	CcSEcCtD
Gamma Hydroxybutyric Acid—Acne—Thalidomide—leprosy	0.00973	0.011	CcSEcCtD
Gamma Hydroxybutyric Acid—Apnoea—Thalidomide—leprosy	0.00966	0.011	CcSEcCtD
Gamma Hydroxybutyric Acid—Accidental injury—Thalidomide—leprosy	0.00925	0.0105	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal stiffness—Thalidomide—leprosy	0.00913	0.0104	CcSEcCtD
Gamma Hydroxybutyric Acid—Viral infection—Thalidomide—leprosy	0.00906	0.0103	CcSEcCtD
Gamma Hydroxybutyric Acid—Bone disorder—Thalidomide—leprosy	0.00906	0.0103	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperbilirubinaemia—Thalidomide—leprosy	0.009	0.0102	CcSEcCtD
Gamma Hydroxybutyric Acid—Thinking abnormal—Thalidomide—leprosy	0.00894	0.0102	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypocalcaemia—Thalidomide—leprosy	0.00894	0.0102	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperuricaemia—Thalidomide—leprosy	0.00883	0.01	CcSEcCtD
Gamma Hydroxybutyric Acid—Leukocytosis—Thalidomide—leprosy	0.00871	0.00989	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypercholesterolaemia—Thalidomide—leprosy	0.00866	0.00983	CcSEcCtD
Gamma Hydroxybutyric Acid—Creatinine increased—Thalidomide—leprosy	0.0086	0.00976	CcSEcCtD
Gamma Hydroxybutyric Acid—Sinusitis—Dapsone—leprosy	0.00839	0.00953	CcSEcCtD
Gamma Hydroxybutyric Acid—Blood uric acid increased—Thalidomide—leprosy	0.00834	0.00946	CcSEcCtD
Gamma Hydroxybutyric Acid—Phosphatase alkaline increased—Thalidomide—leprosy	0.00819	0.00929	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A7—tendon—leprosy	0.00807	0.0678	CbGeAlD
Gamma Hydroxybutyric Acid—Pharyngitis—Dapsone—leprosy	0.00797	0.00905	CcSEcCtD
Gamma Hydroxybutyric Acid—Depressed level of consciousness—Thalidomide—leprosy	0.00791	0.00897	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—eye—leprosy	0.00776	0.0651	CbGeAlD
Gamma Hydroxybutyric Acid—Cramps of lower extremities—Thalidomide—leprosy	0.00752	0.00854	CcSEcCtD
Gamma Hydroxybutyric Acid—Tinnitus—Dapsone—leprosy	0.00749	0.0085	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypertonia—Thalidomide—leprosy	0.00718	0.00815	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperkinesia—Thalidomide—leprosy	0.00714	0.00811	CcSEcCtD
Gamma Hydroxybutyric Acid—Mental disability—Thalidomide—leprosy	0.0071	0.00806	CcSEcCtD
Gamma Hydroxybutyric Acid—Euphoric mood—Thalidomide—leprosy	0.00703	0.00799	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—testis—leprosy	0.007	0.0588	CbGeAlD
Gamma Hydroxybutyric Acid—Lymphadenopathy—Thalidomide—leprosy	0.00697	0.00791	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—nervous system—leprosy	0.00687	0.0577	CbGeAlD
Gamma Hydroxybutyric Acid—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.00683	0.00776	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A7—testis—leprosy	0.00668	0.0561	CbGeAlD
Gamma Hydroxybutyric Acid—Vision blurred—Dapsone—leprosy	0.00659	0.00748	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A7—nervous system—leprosy	0.00656	0.0551	CbGeAlD
Gamma Hydroxybutyric Acid—Injury—Thalidomide—leprosy	0.00647	0.00734	CcSEcCtD
Gamma Hydroxybutyric Acid—Libido decreased—Thalidomide—leprosy	0.00641	0.00727	CcSEcCtD
Gamma Hydroxybutyric Acid—Amnesia—Thalidomide—leprosy	0.00633	0.00718	CcSEcCtD
Gamma Hydroxybutyric Acid—Vertigo—Dapsone—leprosy	0.00628	0.00713	CcSEcCtD
Gamma Hydroxybutyric Acid—Arthritis—Thalidomide—leprosy	0.00611	0.00694	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain in extremity—Thalidomide—leprosy	0.00594	0.00675	CcSEcCtD
Gamma Hydroxybutyric Acid—Disturbance in sexual arousal—Thalidomide—leprosy	0.0059	0.00669	CcSEcCtD
Gamma Hydroxybutyric Acid—Psychotic disorder—Thalidomide—leprosy	0.0058	0.00659	CcSEcCtD
Gamma Hydroxybutyric Acid—Ataxia—Thalidomide—leprosy	0.00559	0.00634	CcSEcCtD
Gamma Hydroxybutyric Acid—Blood creatinine increased—Thalidomide—leprosy	0.00557	0.00632	CcSEcCtD
Gamma Hydroxybutyric Acid—Dehydration—Thalidomide—leprosy	0.00553	0.00627	CcSEcCtD
Gamma Hydroxybutyric Acid—Aspartate aminotransferase increased—Thalidomide—leprosy	0.00535	0.00607	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—nervous system—leprosy	0.00527	0.0443	CbGeAlD
Gamma Hydroxybutyric Acid—Muscular weakness—Thalidomide—leprosy	0.00524	0.00595	CcSEcCtD
Gamma Hydroxybutyric Acid—Alanine aminotransferase increased—Thalidomide—leprosy	0.00524	0.00595	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal distension—Thalidomide—leprosy	0.00517	0.00587	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Dapsone—leprosy	0.00516	0.00586	CcSEcCtD
Gamma Hydroxybutyric Acid—Influenza—Thalidomide—leprosy	0.00514	0.00583	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—tendon—leprosy	0.00514	0.0431	CbGeAlD
Gamma Hydroxybutyric Acid—Pollakiuria—Thalidomide—leprosy	0.00474	0.00539	CcSEcCtD
Gamma Hydroxybutyric Acid—Weight increased—Thalidomide—leprosy	0.00467	0.00531	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Dapsone—leprosy	0.00467	0.0053	CcSEcCtD
Gamma Hydroxybutyric Acid—Weight decreased—Thalidomide—leprosy	0.00465	0.00528	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperglycaemia—Thalidomide—leprosy	0.00463	0.00526	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation NOS—Thalidomide—leprosy	0.00458	0.0052	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation—Thalidomide—leprosy	0.00458	0.0052	CcSEcCtD
Gamma Hydroxybutyric Acid—Depression—Thalidomide—leprosy	0.00457	0.00518	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Dapsone—leprosy	0.00451	0.00512	CcSEcCtD
Gamma Hydroxybutyric Acid—Stomatitis—Thalidomide—leprosy	0.00446	0.00507	CcSEcCtD
Gamma Hydroxybutyric Acid—Haematuria—Thalidomide—leprosy	0.00437	0.00496	CcSEcCtD
Gamma Hydroxybutyric Acid—Epistaxis—Thalidomide—leprosy	0.00432	0.0049	CcSEcCtD
Gamma Hydroxybutyric Acid—Sinusitis—Thalidomide—leprosy	0.0043	0.00488	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—testis—leprosy	0.00425	0.0357	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—nervous system—leprosy	0.00417	0.0351	CbGeAlD
Gamma Hydroxybutyric Acid—Rhinitis—Thalidomide—leprosy	0.00412	0.00468	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypoaesthesia—Thalidomide—leprosy	0.00409	0.00464	CcSEcCtD
Gamma Hydroxybutyric Acid—Pharyngitis—Thalidomide—leprosy	0.00408	0.00463	CcSEcCtD
Gamma Hydroxybutyric Acid—Urinary tract disorder—Thalidomide—leprosy	0.00406	0.00461	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema peripheral—Thalidomide—leprosy	0.00405	0.0046	CcSEcCtD
Gamma Hydroxybutyric Acid—Urethral disorder—Thalidomide—leprosy	0.00403	0.00457	CcSEcCtD
Gamma Hydroxybutyric Acid—Eye disorder—Thalidomide—leprosy	0.00384	0.00436	CcSEcCtD
Gamma Hydroxybutyric Acid—Tinnitus—Thalidomide—leprosy	0.00383	0.00435	CcSEcCtD
Gamma Hydroxybutyric Acid—Cardiac disorder—Thalidomide—leprosy	0.00382	0.00433	CcSEcCtD
Gamma Hydroxybutyric Acid—Angiopathy—Thalidomide—leprosy	0.00373	0.00423	CcSEcCtD
Gamma Hydroxybutyric Acid—Immune system disorder—Thalidomide—leprosy	0.00371	0.00422	CcSEcCtD
Gamma Hydroxybutyric Acid—Mediastinal disorder—Thalidomide—leprosy	0.00371	0.00421	CcSEcCtD
Gamma Hydroxybutyric Acid—Chills—Thalidomide—leprosy	0.00369	0.00419	CcSEcCtD
Gamma Hydroxybutyric Acid—Alopecia—Thalidomide—leprosy	0.00363	0.00412	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Dapsone—leprosy	0.00363	0.00412	CcSEcCtD
Gamma Hydroxybutyric Acid—Mental disorder—Thalidomide—leprosy	0.0036	0.00409	CcSEcCtD
Gamma Hydroxybutyric Acid—Malnutrition—Thalidomide—leprosy	0.00358	0.00406	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Dapsone—leprosy	0.00357	0.00406	CcSEcCtD
Gamma Hydroxybutyric Acid—Tension—Thalidomide—leprosy	0.00351	0.00399	CcSEcCtD
Gamma Hydroxybutyric Acid—Dysgeusia—Thalidomide—leprosy	0.0035	0.00398	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervousness—Thalidomide—leprosy	0.00348	0.00395	CcSEcCtD
Gamma Hydroxybutyric Acid—Back pain—Thalidomide—leprosy	0.00346	0.00393	CcSEcCtD
Gamma Hydroxybutyric Acid—Muscle spasms—Thalidomide—leprosy	0.00344	0.00391	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Dapsone—leprosy	0.00339	0.00385	CcSEcCtD
Gamma Hydroxybutyric Acid—Vision blurred—Thalidomide—leprosy	0.00337	0.00383	CcSEcCtD
Gamma Hydroxybutyric Acid—Tremor—Thalidomide—leprosy	0.00335	0.00381	CcSEcCtD
Gamma Hydroxybutyric Acid—Anaemia—Thalidomide—leprosy	0.00331	0.00376	CcSEcCtD
Gamma Hydroxybutyric Acid—Agitation—Thalidomide—leprosy	0.00329	0.00373	CcSEcCtD
Gamma Hydroxybutyric Acid—Vertigo—Thalidomide—leprosy	0.00322	0.00365	CcSEcCtD
Gamma Hydroxybutyric Acid—Syncope—Thalidomide—leprosy	0.00321	0.00364	CcSEcCtD
Gamma Hydroxybutyric Acid—Palpitations—Thalidomide—leprosy	0.00316	0.00359	CcSEcCtD
Gamma Hydroxybutyric Acid—Loss of consciousness—Thalidomide—leprosy	0.00315	0.00357	CcSEcCtD
Gamma Hydroxybutyric Acid—Convulsion—Thalidomide—leprosy	0.0031	0.00352	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypertension—Thalidomide—leprosy	0.00309	0.00351	CcSEcCtD
Gamma Hydroxybutyric Acid—Arthralgia—Thalidomide—leprosy	0.00305	0.00346	CcSEcCtD
Gamma Hydroxybutyric Acid—Chest pain—Thalidomide—leprosy	0.00305	0.00346	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Thalidomide—leprosy	0.00305	0.00346	CcSEcCtD
Gamma Hydroxybutyric Acid—Anxiety—Thalidomide—leprosy	0.00304	0.00345	CcSEcCtD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00303	0.00343	CcSEcCtD
Gamma Hydroxybutyric Acid—Dry mouth—Thalidomide—leprosy	0.00298	0.00338	CcSEcCtD
Gamma Hydroxybutyric Acid—Confusional state—Thalidomide—leprosy	0.00295	0.00334	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema—Thalidomide—leprosy	0.00292	0.00332	CcSEcCtD
Gamma Hydroxybutyric Acid—Infection—Thalidomide—leprosy	0.0029	0.00329	CcSEcCtD
Gamma Hydroxybutyric Acid—Shock—Thalidomide—leprosy	0.00287	0.00326	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervous system disorder—Thalidomide—leprosy	0.00286	0.00325	CcSEcCtD
Gamma Hydroxybutyric Acid—Skin disorder—Thalidomide—leprosy	0.00284	0.00322	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Thalidomide—leprosy	0.00282	0.00321	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Thalidomide—leprosy	0.00278	0.00316	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Thalidomide—leprosy	0.00266	0.00302	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Thalidomide—leprosy	0.00264	0.003	CcSEcCtD
Gamma Hydroxybutyric Acid—Paraesthesia—Thalidomide—leprosy	0.00262	0.00298	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Thalidomide—leprosy	0.0026	0.00296	CcSEcCtD
Gamma Hydroxybutyric Acid—Somnolence—Thalidomide—leprosy	0.0026	0.00295	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspepsia—Thalidomide—leprosy	0.00257	0.00292	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Thalidomide—leprosy	0.00254	0.00288	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Thalidomide—leprosy	0.00252	0.00286	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Thalidomide—leprosy	0.00252	0.00286	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Thalidomide—leprosy	0.0025	0.00284	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Thalidomide—leprosy	0.0025	0.00284	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Thalidomide—leprosy	0.00241	0.00273	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Thalidomide—leprosy	0.00239	0.00271	CcSEcCtD
Gamma Hydroxybutyric Acid—Urticaria—Thalidomide—leprosy	0.00232	0.00263	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Thalidomide—leprosy	0.00231	0.00262	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Thalidomide—leprosy	0.00215	0.00244	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Thalidomide—leprosy	0.0021	0.00238	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Thalidomide—leprosy	0.002	0.00227	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Thalidomide—leprosy	0.00193	0.00219	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Thalidomide—leprosy	0.00186	0.00211	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Thalidomide—leprosy	0.00184	0.00209	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Thalidomide—leprosy	0.00184	0.00209	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Thalidomide—leprosy	0.00183	0.00208	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Thalidomide—leprosy	0.00173	0.00197	CcSEcCtD
